Your Guide to Financial Freedom
Eli Lilly Delivers Blockbuster Quarter Fueled by GLP-1 Franchise Eli Lilly and Co. (NYSE: LLY) shares surged Wednesday after the pharmaceutical giant reported a “beat-and-raise” quarter that underscored the insatiable demand for its incretin-based therapies. The stock broke into a new buy zone, rewarding investors who have bet on the company’s dual franchises in type … Read more
Key Drivers Behind Mortgage Rate Projections Mortgage rates have remained elevated over the past few years, leaving homebuyers and refinancers wondering where rates are headed through 2030. The answer lies primarily in the 10-year U.S. Treasury yield, which serves as the benchmark for 30-year fixed mortgage rates. Lenders add a spread over this yield to … Read more
Eli Lilly Shares Jump on Revised Guidance and GLP-1 Momentum Eli Lilly and Co. (LLY) shares surged as much as 7% in Wednesday trading after the pharmaceutical giant lifted its full-year 2026 revenue forecast, citing robust demand for its glucagon-like peptide-1 (GLP-1) receptor agonist treatments. The Indianapolis-based drugmaker now expects revenue between $85 billion and … Read more
Shopify Delivers Blowout Quarter, Shattering Margin Concerns Shopify Inc. (NYSE: SHOP) shares exploded higher Wednesday after the Canadian e-commerce platform reported second-quarter results that crushed Wall Street expectations, effectively silencing concerns that heavy artificial intelligence investments would compress margins. The stock surged over 20% in premarket trading, adding roughly $20 billion in market capitalization. Gross … Read more
Market Overview: Mixed Signals from Futures and Earnings Dow Jones futures edged higher early Wednesday alongside S&P 500 and Nasdaq futures, signaling a cautiously optimistic start to the session. The major indexes closed Tuesday with the Dow and S&P 500 notching fresh record highs, while the Nasdaq Composite reclaimed its 50-day moving average—a key technical … Read more
The second-quarter earnings season is delivering a powerful narrative: artificial intelligence infrastructure spending is reshaping corporate America, even as consumer-facing giants flash warning signs. With S&P 500 earnings growth projected at 47.5% year-over-year—far exceeding the 16.4% five-year average—investors are witnessing a historic divergence between AI beneficiaries and traditional growth stocks. AI Cloud Leaders Drive Outperformance … Read more
Market Overview: Records Amid Mixed Earnings U.S. equity benchmarks closed at fresh highs on Tuesday, with the S&P 500 and Dow Jones Industrial Average surging as falling oil prices and a robust earnings season overshadowed geopolitical tensions. The broad-market index climbed on broad-based participation, while the blue-chip gauge benefited from strong results from industrial heavyweights … Read more
Veteran economist and longtime Bitcoin skeptic Peter Schiff has doubled down on his bearish stance, warning that the cryptocurrency’s recent pullback may be just the beginning of a significantly larger selloff. His comments come as Bitcoin (BTC-USD) trades around $64,371 — down more than 50% from its all-time high above $120,000 reached in October 2025. … Read more
Agilent Technologies Inc. (NYSE: A) has extended its diagnostics franchise into a critical oncology niche. On July 23, European regulators certified the company’s PD-L1 IHC 22C3 pharmDx test (Code SK006) as a companion diagnostic for epithelial ovarian, fallopian tube, and primary peritoneal carcinoma. The approval enables pathologists to identify patients who may benefit from Merck’s … Read more
Market Rally Driven by Geopolitical Relief and Economic Strength U.S. equity markets closed sharply higher on Monday, with major indices posting multi-week highs as easing tensions in the Middle East triggered a sharp decline in crude oil prices and alleviated inflation concerns. The S&P 500 Index ($SPX) rose +1.48% to reach a two-month high, the … Read more